Gokul Das, PhD of Roswell Park, Department of Pharmacology and Therapeutics gives an overview of his abstract, Novel effect of tamoxifen therapy: disruption of ER-p53 interaction leading to altered gene expression profile in human breast tumors, which was presented at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Advertisement
Advertisement